[Addiction: what's new in 2022].

Addictions appear everywhere, mutate, transform with new products and behaviors, playing on our painstaking efforts to try to control them. Drawn into this current, the impression that dominates invites more to understand and to coax rather than to fight. Addictions are our condition, let's deal with it, rather than fight against them.

Impaired Specificity of Future Thinking in Alcohol Use Disorders.

Background: While there has been a body of work that has investigated past thinking in individuals with alcohol use disorders (AUD), little is known about future thinking in these individuals.

Methods: We invited participants with AUD and control participants to construct past and future events. We have also investigated the relationship between constructing past and future events and depression.

Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions.

Attention Deficit Hyperactivity Disorder (ADHD) is highly prevalent among adults with addictive disorders, but little is known about addiction patterns associated with ADHD diagnosis. This study examined addiction severity in patients with co-occurring addictive disorders and ADHD controlling for the potential influence of associated psychiatric comorbidity. Data were collected in French outpatient addiction treatment centers.

[Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].

Background: Schizophrenia is a chronic, relapsing, mental disorder, and lack of adherence is a common and severe problem in such patients leadingto global and heavy consequences for patients (relapses, hospitalizations, impaired quality of life…), for the family and for society. Improved understanding of the underlying reasons will help to form intervention strategies relevant to the context.

Objectives: We aimed to assess medication adherence among stable patients suffering from schizophrenia and to identify factors associated with non-adherence.

[Safety of long-term nicotine use: An ongoing debate].

Introduction: Long-term nicotine use has been proposed as a risk-reduction strategy in smokers unwilling or unable to quit. However, its safety remains debated.

Methods: Analysis of publications identified in PubMed, Toxibase, Google Scholar and in the Food and Drug Administration, and French National Authority for Health websites.

Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.

Background: The latest French good practice recommendations (GPRs) for the screening, prevention, and treatment of alcohol misuse were recently published in partnership with the European Federation of Addiction Societies (EUFAS). This article aims to synthesize the GPRs focused on the pharmacotherapy of alcohol dependence.

Methods: A four-member European steering committee defined the questions that were addressed to an 18-member multiprofessional working group (WG).

[Policy and routine practice for smoking cessation in France].

In France, daily tobacco consumption increased among adults between 18 and 75 years between 2005 and 2010, particularly women. At 17 age-old, it raised 10% between 2008 and 2011 (32.7% in boys and 30.

[Stress and smoking in treatment-seeking smokers].

Fear of not controlling stress is the most frequently reported obstacle to smoking cessation. We report a retrospective study involving 70 smokers whose files were randomly selected from a smoking cessation clinic's recruitment. Stress management as a motive to smoke (SMMS) was systematically explored at the first visit, before quit date.

[From nicotine dependence to addictology].

The concept of addiction has developed in France since the beginning of the 2000s. It has justified by common clinical aspects, high level of co-morbidities between addictions to psychoactive drugs, common cognitive and behavioral mechanisms, the impact of comparable psychological and genetic factors, the same neurobiological mechanisms and the same therapy options in many cases. Although some specificities remain in smoking management: absence of intoxication and abuse diagnosis in DSM-IV, less consensual politics of harm reduction, and own pharmacotherapy solutions.

[Current therapeutic strategies for tobacco dependence].

Smoking remains the first preventable cause of premature death worldwide. Despite the knowledge of adverse consequences of smoking, many smokers have difficulties to quit for good. This is due to the addictive nature of tobacco, at least as strong as the one of illicit drugs.